# clm_F100EC2AA0AB

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 7,313,612,000 United States dollar  
valid_from: 2012-03-31  
valid_to: 2012-06-30  
published: 2012-05-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_67DBD97EDB58  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 7,313,612,000 United States dollar", as of 2012-03-31 (until 2012-06-30). Claim clm_F100EC2AA0AB, https://asof.is/claim/clm_F100EC2AA0AB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000144530512001487/0001445305-12-001487-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2012, filed 2012-05-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000144530512001487/0001445305-12-001487-index.htm (primary, SEC EDGAR 10-Q Q1 FY2012, published 2012-05-04)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 6,738,856,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_F100EC2AA0AB](/claim/clm_F100EC2AA0AB.md) | [clm_019E95D10520](/claim/clm_019E95D10520.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.